David Einhorn acquired 1.27 Million Coya Therapeutics shares worth $10.5 Million. That's 0.48% of their equity portfolio (25th largest holding). The investor owns 15.07% of the outstanding Coya Therapeutics stock. The stake costed the investor $6.6 Million, netting the investor a gain of 59% so far.